Form 8-K INNO HOLDINGS INC. For: Jul 10
false
0001961847
0001961847
2026-07-10
2026-07-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES... (continue reading...)
Form D/A USEDC 2026 Drilling Fund
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form D Series 18-5, a series
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 425 Axalta Coating Systems Filed by: AKZO NOBEL NV
Filed by Akzo Nobel N.V. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Axalta Coating Systems Ltd. (Commission File No.: 001-36733) Date: July 13, 2026
The following is a press release published by Akzo Nobel N.V. on July 13th, 2026:
Akzo Nobel N.V.
Media release
July 13, 2026
AkzoNobel confirms receiving offers... (continue reading...)
Form 144 KB HOME Filed by: McGibney Robert V.
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K HINES GLOBAL INCOME TRUS For: Jun 23
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 487 FT 13099
-
Form 487 FT 13167
-
Form 10-Q Jubilant Flame Internati For: May 31
-
Form 487 FT 13166
-
Form 497 Rayliant Funds Trust
-
Form 424B2 UBS AG
-
Form 13F-HR Echo45 Advisors LLC For: Jun 30
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form POSASR Esperion Therapeutics,
-
Form D AlphaKeys ExodusPoint
-
Form D Dendrion Innoblative 1,
-
Form POS AM Esperion Therapeutics,
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 424B2 MORGAN STANLEY
-
Form POS AM Esperion Therapeutics,
-
Form POS462B Esperion Therapeutics,
-
Form 4 Fundrise Income Real For: Jul 10 Filed by: Starr Gayle P
-
Form 4/A H2O AMERICA For: Jul 07 Filed by: ATLAS Infrastructure Partners (UK) Ltd.
-
Form 424B2 UBS AG
-
Form D FCP Venture X QP LLC,
-
Form 497 Tidal Trust III
-
Form D Series 18-4, a series
-
Form 497K EA Series Trust
-
Form POS AM Esperion Therapeutics,
-
Form F-6EF Amundi S.A./ADR Filed by: BANK OF NEW YORK / ADR DIVISION
-
Form 4 Texas Pacific Land Corp For: Jul 10 Filed by: HORIZON KINETICS ASSET MANAGEMENT LLC
-
Form POS AM Esperion Therapeutics,
-
Form 13F-HR DAVENPORT & Co LLC For: Jun 30
-
Form 6-K Mint Inc Ltd For: Jul 13
-
Form 424B2 UBS AG
-
Form 424B2 MORGAN STANLEY
-
Form D/A Institutional Drilling
-
Form POS AM Esperion Therapeutics,
-
Form N-PX Lindsell Train Ltd For: Jun 30
-
Form 497 EA Series Trust
-
Form CERT Shell Finance US Inc.
-
Form 424B2 MORGAN STANLEY
-
Form N-PX Intelligent Financial For: Jun 30
-
Form POS AM Esperion Therapeutics,
-
Form CERT Shell plc
-
Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC
-
Form FWP GS Finance Corp. Filed by: GS Finance Corp.
-
Form 424B2 UBS AG
-
Form D MDHGEB5 LLC
-
Form N-CEN Peachtree Alternative For: Apr 30
-
Form S-8 POS Esperion Therapeutics,
-
Form 424B2 CITIGROUP INC
-
Form S-8 POS Esperion Therapeutics,
